Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient.

about

Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient.

Item

http://www.wikidata.org/entity/Q46362200

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@en

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@nl

type

Item

label

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@en

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@nl

prefLabel

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@en

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@nl

P1476

Tumor shape pulmonary mucormyc ...... illosis in a diabetic patient.

@en

P2093

Chantal Raherison

http://www.w3.org/2001/XMLSchema#string

Elodie Blanchard

http://www.w3.org/2001/XMLSchema#string

Emilie Catherinot

http://www.w3.org/2001/XMLSchema#string

Fanny Lanternier

http://www.w3.org/2001/XMLSchema#string

Frédéric Gabriel

http://www.w3.org/2001/XMLSchema#string

Frédéric Grenouillet

http://www.w3.org/2001/XMLSchema#string

Hugues Bégueret

http://www.w3.org/2001/XMLSchema#string

Jacques Jougon

http://www.w3.org/2001/XMLSchema#string

Manal Abdel Fattah

http://www.w3.org/2001/XMLSchema#string

Sophie Point

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes and mucormycosis: a complex interplay

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

Pulmonary mucormycosis: the last 30 years.

Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

How I treat mucormycosis.

The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

Epidemiology and treatment of mucormycosis.

Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes.

P304

13-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MMCR.2017.08.001

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29188178

http://www.w3.org/2001/XMLSchema#string

P921

aspergillosis

P932

5695648

http://www.w3.org/2001/XMLSchema#string